Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease: Diagnostic and Additional Therapeutic Consequences

Letter to the EditorPhysiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease: Diagnostic and Additional Therapeutic ConsequencesJo G. R. De Mey, Maria Bloksgaard, and Christian AalkjærJo G. R. De MeyUniversity of Southern Denmark, Odense, DenmarkAarhus University, Aarhus, Denmark, Maria BloksgaardUniversity of Southern Denmark, Odense, Denmark, and Christian AalkjærAarhus University, Aarhus, DenmarkPublished Online:06 Feb 2019https://doi.org/10.1152/physiol.00053.2018MoreSectionsPDF (72 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat to the editor: In Physiology, we read with interest the review article by Allaqaband et al. (1) stressing the contribution of coronary microvascular dysfunction to coronary artery disease (CAD) and thus the need for novel arteriole-specific therapeutic approaches. The authors are congratulated for the crisp summary of their pioneering works indicating that, in coronary arterioles of CAD patients, endothelial release of nitric oxide (NO) is shifted to hydrogen peroxide (H2O2). The cardiovascular research community is increasingly aware of the important contributions of microvascular dysfunction to cardiac (1) and neurodegenerative diseases (4). Here, we formulate diagnostic and additional potential therapeutic consequences of the subject reviewed by the Milwaukee group.The experiments summarized by Allaqaband et al. (1) showed that the transition of endothelium-derived NO to H2O2 can be observed in not only coronary but also adipose tissue arterioles of CAD patients. This suggests that it might be monitored noninvasively in the periphery with predictive value for the coronary circulation. Various established and novel non-invasive approaches of the human microcirculation and human resistance artery function are available to accomplish this (7). They include venous occlusion plethysmography, nailfold capillaroscopy, retinoscopy (22), dynamic optical coherence tomography (2, 20, 21), and label-free photoacoustic imaging (16, 17).Demonstration of endothelium-derived H2O2 in isolated arterioles in vitro involves 1) resistance to treatment with an inhibitor of NO synthase, 2) inhibition by catalase (scavenger of H2O2), and 3) increased fluorescence of a H2O2-selective probe, which cannot all be used in the intact human in vivo. In theory, ebselen [alternative scavenger of H2O2 used in human research (23)] and the use of two-photon microscopy on the skin [reviewed by Guo et al. (10)] may fill these gaps in the future. Still, the experimental evidence summarized by Allaqaband et al. (1) invites consideration of two forms of dysfunction of endothelium-dependent vasodilatation: quantitative and qualitative endothelial dysfunction. In the former, the amplitude of the vasodilator response to an endothelium-dependent stimulus is reduced. In the latter, the magnitude of the endothelium-dependent vasodilatation is maintained but no longer mediated by NO {i.e., resistant to inhibitors of NO synthase but blocked by tetraethyl ammonium [inhibitor of endothelium-dependent hyperpolarization in the human forearm (11)] and possibly by catalase or ebselen}. Determining whether the latter is a dysfunction or a compensation will require monitoring of the damage done by endothelium-derived H2O2. In contrast to the protein changes induced by peroxynitrite (ONOO–, the product of NO and superoxide anion) (19), there is no consensus on fingerprints of H2O2-induced vascular damage (8). Guidelines have been proposed to facilitate high-quality measurements of both reactive oxygen species and reactive nitrogen species (9), yet identification of markers at all levels (from laboratory research to clinic) of specific H2O2-induced damage is missing. This would be highly relevant to not only coronary microvascular dysfunction but also to cerebrovascular causes of neurodegeneration (4).Most of the experimental evidence reviewed by Allaqaband et al. (1) was obtained in isolated coronary and adipose tissue arterioles from patients with and without CAD who were constricted with endothelin-1 in vitro. We reported (14, 15) that the relaxing responses of pericardial resistance arteries from patients requiring cardio-thoracic surgery (>70% with CAD) to the endothelium-dependent vasodilator bradykinin are 1) blocked by an inhibitor of NO synthase during contraction induced by depolarization or by a thromboxane A2 mimetic and 2) are blocked by catalase, but not inhibitor of NO-synthase, during contraction induced by endothelin-1. This may put endothelin-1 in the center of the transition of endothelium-derived NO to H2O2 advocated in the elegant review by Allaqaband et al. (1). It also adds inhibitors of endothelin-converting enzyme, inhibitors of multiple metalloproteases (13, 18), and antagonists of endothelin receptors (5) to the arteriole-specific therapeutic considerations elaborated by Allaqaband et al. (1).A shift of endothelium-derived NO to H2O2 may not be the end of the line. In coronary arterioles and pericardial resistance arteries from CAD patients, a statistically significant vasodilatation in response to bradykinin persists when NO synthase is inhibited and H2O2 is scavenged (12, 14). In the coronary vessels, this could be attributed to unmasking of endothelium-derived epoxyeicosatrienoic acid produced from arachidonic acid by endothelial cytochrome P450 and activating smooth muscle large conductance calcium-activated K+ channels (12). Cytochrome P450 is inhibited by NO (3) and by H2O2 (12), but can be activated when the bioavailability of the radicals is reduced. In 2016, these interactions were among others reviewed by Ellinsworth et al. (6).A final word of caution is that properties of arterioles isolated from CAD patients can result from the risk factors that contributed to the development of large coronary artery disease, from the consequences of CAD, and from the various drugs that CAD patients are treated with before they are referred to coronary artery bypass surgery. It is of note, in this respect, that the vessels from these patients exhibit substantial endothelium-dependent vasodilator responses to bradykinin and increased shear stress (1, 14). The potency and efficacy of these endothelium-dependent stimuli is similar in these vessels compared with those reported for arterioles and resistance arteries from individuals without CAD or its extensive chronic drug treatment. The endothelium-derived mediator, however, differs; i.e., qualitative rather than quantitative endothelial dysfunction. So far, it cannot be excluded that microvascular endothelium-dependent vasodilatation is impaired during development of coronary vascular dysfunction and restored via alternative mechanisms during chronic treatment with a statin, an antithrombotic, and one or more blood pressure-lowering drugs.No conflicts of interest, financial or otherwise, are declared by the author(s).References1. Allaqaband H, Gutterman DD, Kadlec AO. Physiological consequences of coronary arteriolar dysfunction and its influence on cardiovascular disease. Physiology (Bethesda) 33: 338–347, 2018. Link | ISI | Google Scholar2. Baran U, Wang RK. Review of optical coherence tomography based angiography in neuroscience. Neurophotonics 3: 010902, 2016. doi:10.1117/1.NPh.3.1.010902. Crossref | PubMed | ISI | Google Scholar3. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94: 3341–3347, 1996. doi:10.1161/01.CIR.94.12.3341. Crossref | PubMed | ISI | Google Scholar4. Bosetti F, Galis ZS, Bynoe MS, Charette M, Cipolla MJ, Del Zoppo GJ, Gould D, Hatsukami TS, Jones TL, Koenig JI, Lutty GA, Maric-Bilkan C, Stevens T, Tolunay HE, Koroshetz W; Small Blood Vessels: Big Health Problems" Workshop Participants. "Small blood vessels: big health problems?": scientific recommendations of the National Institutes of Health Workshop. J Am Heart Assoc 5: e004389, 2016. doi:10.1161/JAHA.116.004389. Crossref | PubMed | ISI | Google Scholar5. Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Endothelin. Pharmacol Rev 68: 357–418, 2016. doi:10.1124/pr.115.011833. Crossref | PubMed | ISI | Google Scholar6. Ellinsworth DC, Sandow SL, Shukla N, Liu Y, Jeremy JY, Gutterman DD. Endothelium-derived hyperpolarization and coronary vasodilation: diverse and integrated roles of epoxyeicosatrienoic acids, hydrogen peroxide, and gap junctions. Microcirculation 23: 15–32, 2016. doi:10.1111/micc.12255. Crossref | PubMed | ISI | Google Scholar7. Eriksson S, Nilsson J, Sturesson C. Non-invasive imaging of microcirculation: a technology review. Med Devices (Auckl) 7: 445–452, 2014. PubMed | Google Scholar8. Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, Taylor EL, Oettrich J, Ruskovska T, Gasparovic AC, Cuadrado A, Weber D, Poulsen HE, Grune T, Schmidt HH, Ghezzi P. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 23: 1144–1170, 2015. doi:10.1089/ars.2015.6317. Crossref | PubMed | ISI | Google Scholar9. Griendling KK, Touyz RM, Zweier JL, Dikalov S, Chilian W, Chen YR, Harrison DG, Bhatnagar A; American Heart Association Council on Basic Cardiovascular Sciences. Measurement of reactive oxygen species, reactive nitrogen species, and redox-dependent signaling in the cardiovascular system: a scientific statement from the American Heart Association. Circ Res 119: e39–e75, 2016. doi:10.1161/RES.0000000000000110. Crossref | PubMed | ISI | Google Scholar10. Guo H, Aleyasin H, Dickinson BC, Haskew-Layton RE, Ratan RR. Recent advances in hydrogen peroxide imaging for biological applications. Cell Biosci 4: 64, 2014. doi:10.1186/2045-3701-4-64. Crossref | PubMed | ISI | Google Scholar11. Honing ML, Smits P, Morrison PJ, Rabelink TJ. Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization. Hypertension 35: 1314–1318, 2000. doi:10.1161/01.HYP.35.6.1314. Crossref | PubMed | ISI | Google Scholar12. Larsen BT, Gutterman DD, Sato A, Toyama K, Campbell WB, Zeldin DC, Manthati VL, Falck JR, Miura H. Hydrogen peroxide inhibits cytochrome p450 epoxygenases: interaction between two endothelium-derived hyperpolarizing factors. Circ Res 102: 59–67, 2008. doi:10.1161/CIRCRESAHA.107.159129. Crossref | PubMed | ISI | Google Scholar13. Lemkens P, Nelissen J, Meens MJ, Fazzi GE, Janssen GJ, Debets JJ, Janssen BJ, Schiffers PM, De Mey JG. Impaired flow-induced arterial remodeling in DOCA-salt hypertensive rats. Hypertens Res 35: 1093–1101, 2012. doi:10.1038/hr.2012.94. Crossref | PubMed | ISI | Google Scholar14. Leurgans TM, Bloksgaard M, Brewer JR, Bagatolli LA, Fredgart MH, Rosenstand K, Hansen ML, Rasmussen LM, Irmukhamedov A, De Mey JG. Endothelin-1 shifts the mediator of bradykinin-induced relaxation from NO to H2O2 in resistance arteries from patients with cardiovascular disease. Br J Pharmacol 173: 1653–1664, 2016. doi:10.1111/bph.13467. Crossref | PubMed | ISI | Google Scholar15. Leurgans TM, Bloksgaard M, Irmukhamedov A, Riber LP, De Mey JGR. Relaxing responses to hydrogen peroxide and nitric oxide in human pericardial resistance arteries stimulated with endothelin-1. Basic Clin Pharmacol Toxicol 122: 74–81, 2018. doi:10.1111/bcpt.12843. Crossref | PubMed | ISI | Google Scholar16. Matsumoto Y, Asao Y, Sekiguchi H, Yoshikawa A, Ishii T, Nagae KI, Kobayashi S, Tsuge I, Saito S, Takada M, Ishida Y, Kataoka M, Sakurai T, Yagi T, Kabashima K, Suzuki S, Togashi K, Shiina T, Toi M. Visualising peripheral arterioles and venules through high-resolution and large-area photoacoustic imaging. Sci Rep 8: 14930, 2018. doi:10.1038/s41598-018-33255-8. Crossref | PubMed | ISI | Google Scholar17. Matsumoto Y, Asao Y, Yoshikawa A, Sekiguchi H, Takada M, Furu M, Saito S, Kataoka M, Abe H, Yagi T, Togashi K, Toi M. Label-free photoacoustic imaging of human palmar vessels: a structural morphological analysis. Sci Rep 8: 786, 2018. doi:10.1038/s41598-018-19161-z. Crossref | PubMed | ISI | Google Scholar18. Nelissen J, Lemkens P, Sann H, Bindl M, Bassissi F, Jasserand D, De Mey JG, Janssen BJ. Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme. Life Sci 91: 587–592, 2012. doi:10.1016/j.lfs.2012.01.015. Crossref | PubMed | ISI | Google Scholar19. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315–424, 2007. doi:10.1152/physrev.00029.2006. Link | ISI | Google Scholar20. Schuh S, Holmes J, Ulrich M, Themstrup L, Jemec GBE, De Carvalho N, Pellacani G, Welzel J. Imaging blood vessel morphology in skin: dynamic optical coherence tomography as a novel potential diagnostic tool in dermatology. Dermatol Ther (Heidelb) 7: 187–202, 2017. doi:10.1007/s13555-017-0175-4. Crossref | PubMed | ISI | Google Scholar21. Ulrich M, Themstrup L, de Carvalho N, Ciardo S, Holmes J, Whitehead R, Welzel J, Jemec GBE, Pellacani G. Dynamic optical coherence tomography of skin blood vessels - proposed terminology and practical guidelines. J Eur Acad Dermatol Venereol 32: 152–155, 2018. doi:10.1111/jdv.14508. Crossref | PubMed | ISI | Google Scholar22. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med 351: 2310–2317, 2004. doi:10.1056/NEJMra032865. Crossref | PubMed | ISI | Google Scholar23. Yamaguchi T, Sano K, Takakura K, Saito I, Shinohara Y, Asano T, Yasuhara H; Ebselen Study Group. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Stroke 29: 12–17, 1998. doi:10.1161/01.STR.29.1.12. Crossref | PubMed | ISI | Google Scholar Download PDF Previous Back to Top FiguresReferencesRelatedInformation More from this issue > Volume 34Issue 2March 2019Pages 82-83 Copyright & PermissionsCopyright © 2019 Int. Union Physiol. Sci./Am. Physiol. Soc.https://doi.org/10.1152/physiol.00053.2018PubMed30724126History Received 16 November 2018 Accepted 5 December 2018 Published online 6 February 2019 Published in print 1 March 2019 Metrics